Record Details

Fungal infections today: size of the problem and focus on the initial cost of therapy with echinocandin

Farmeconomia

View Archive Info
 
 
Field Value
 
Title Fungal infections today: size of the problem and focus on the initial cost of therapy with echinocandin
 
Creator Venditti, Mario
 
Subject Pharmacoeconomics; Health economics
Invasive candidasis; Cost of therapy; Candins
 
Description Three candins had been approved for the treatment of invasive candidiasis (IC): caspofungin, micafungin, and anidulafungin. Different drugs are associated with different needs for dose adjustment which might affect the total cost. A Spanish economic analysis estimated the budget impact of caspofungin, micafungin and anidulafungin in the treatment of 100 patients with invasive candidiasis from the perspective of the Spanish hospital pharmacy setting. It has demonstrated that patients treated with anidulafungin did not required dose adjustment unlike caspofungin and micafungin, and the use of anidulafungin in the treatment of adult non-neutropenic patients with invasive candidiasis is a cost saving treatment option, from the pharmacy department perspective in Spain. The aim of this study was to estimate the initial costs of therapy with caspofungin, micafungin, and anidulafungin in the perspective of the Italian hospital setting.
 
Publisher SEEd Medical Publishers
 
Contributor —
 
Date 2010-06-15
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
—
 
Format application/pdf
 
Identifier https://journals.seedmedicalpublishers.com/index.php/FE/article/view/181
10.7175/fe.v11i2.181
 
Source Farmeconomia. Health economics and therapeutic pathways; Vol 11, No 2 (2010); 55-62
2240-256X
 
Language eng
 
Relation https://journals.seedmedicalpublishers.com/index.php/FE/article/view/181/168
 
Coverage —
—
—
 
Rights Copyright (c) 2010 Farmeconomia. Health economics and therapeutic pathways
http://creativecommons.org/licenses/by-nc/4.0